Dyslipidemia Therapeutics Market
Dyslipidemia Therapeutics Market Study by Low-density Lipoproteins (LDL) and Triglycerides for Hospital Pharmacies, Drug Stores, and Retail Stores from 2023 to 2033
Analysis of Dyslipidemia Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Author:
Md Sanaullah
Editor:
Anushree Karale
- FACT2928MR
- 06 Apr 2023
- Healthcare
- 170 Pages
- 33 Tables
- 141 Figures
- Base Value(2023): 41.55 Bn
- CAGR: 2.5%
Table of Content
- 1. Executive Summary
- 2. Market Introduction
- 3. Market Dynamics
- 4. Global Market Analysis and Forecast
- 4.1. Global Market Analysis by Type
- 4.1.1. Low-density Lipoproteins (LDL)
- 4.1.2. Triglycerides
- 4.2. Market Analysis by Drug Class
- 4.2.1. Statins
- 4.2.2. Non-Statins
- 4.2.2.1. PCSK9 inhibitors
- 4.2.2.2. Cholesterol absorption inhibitors
- 4.2.2.3. Bile Acid resins
- 4.2.2.4. Fibrate
- 4.2.2.5. Others
- 4.2.3. Combination Drugs
- 4.3. Market Analysis by Distribution Channel
- 4.3.1. Hospitals Pharmacies
- 4.3.2. Drug Stores
- 4.3.3. Retail Stores
- 4.3.4. Mail Order Pharmacies
- 4.1. Global Market Analysis by Type
- 5. North America Market Analysis
- 6. Latin America Market Analysis
- 7. Europe Market Analysis
- 8. CIS & Russia Market Analysis
- 9. Asia Pacific Excluding Japan & China Market Analysis
- 10. China Market Analysis
- 11. Japan Market Analysis
- 12. MEA Market Analysis
- 13. Competitive Assessment
- 14. Company Profiles
- 14.1. AstraZeneca
- 14.2. Kowa Pharmaceuticals America, Inc.
- 14.3. Merck & Co.
- 14.4. Pfizer
- 14.5. Sanofi
- 14.6. Amgen
- 14.7. Novelion Therapeutics
- 14.8. Mylan
- 14.9. Abbott Laboratories
- 14.10. Novartis AG
- 15. Assumptions and Acronyms Used
- 16. Research Methodology
List Of Table
Table 1: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 2: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 3: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 4: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 5: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 6: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 7: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 8: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 9: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 10: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 11: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 12: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 13: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 14: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 15: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 16: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 17: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 18: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 19: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 20: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 21: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 22: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 23: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 24: Japan Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 25: Japan Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 26: Japan Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 27: China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 28: China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 29: China Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 30: MEA Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 31: MEA Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
Table 32: MEA Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 33: MEA Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
List Of Figures
Figure 1: Global Market Value Share 2023E, By Region
Figure 2: Global Market Value Share, By Type
Figure 3: Global Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 4: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 5: Global Market Attractiveness Analysis, By Region
Figure 6: Global Market Value Share Analysis, By Region, 2022 & 2033, By Region
Figure 7: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Low-density Lipoproteins (LDL)
Figure 8: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Low-density Lipoproteins (LDL)
Figure 9: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Triglycerides
Figure 10: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Triglycerides
Figure 11: Global Market Attractiveness Analysis, By Type
Figure 12: Global Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 13: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Statins
Figure 14: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Statins
Figure 15: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Non-Statins
Figure 16: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Non-Statins
Figure 17: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Combinations Drugs
Figure 18: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Combinations Drugs
Figure 19: Global Market Attractiveness Analysis, By Drug Class
Figure 20: Global Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 21: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Hospitals Pharmacies
Figure 22: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Hospitals Pharmacies
Figure 23: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Drug Stores
Figure 24: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Drug Stores
Figure 25: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Retail Stores
Figure 26: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Retail Stores
Figure 27: Global Market Size (US$ Mn) Analysis, 2018 to 2022, By Mail Order Pharmacies
Figure 28: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Mail Order Pharmacies
Figure 29: Global Market Attractiveness Analysis, By Distribution Channel
Figure 30: Global Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 31: North America Market, Snapshot
Figure 32: North America Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 33: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 34: North America Market Value Share, by Country Type (2022A)
Figure 35: North America Market Value Share, by Type (2022A)
Figure 36: North America Market Value Share, by Drug Class (2022A)
Figure 37: North America Market Value Share, by Distribution Channel (2022A)
Figure 38: North America Market Attractiveness Analysis, By Country
Figure 39: North America Market Value Share Analysis, By Region, 2022 & 2033, By Country
Figure 40: North America Market Attractiveness Analysis, By Type
Figure 41: North America Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 42: North America Market Attractiveness Analysis, By Drug Class
Figure 43: North America Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 44: North America Market Attractiveness Analysis, By Distribution Channel
Figure 45: North America Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 46: Latin America Market, Snapshot
Figure 47: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 48: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 49: Latin America Market Value Share, by Country Type (2022A)
Figure 50: Latin America Market Value Share, by Type (2022A)
Figure 51: Latin America Market Value Share, by Drug Class (2022A)
Figure 52: Latin America Market Value Share, by Distribution Channel (2022A)
Figure 53: Latin America Market Attractiveness Analysis, By Country
Figure 54: Latin America Market Value Share Analysis, By Region, 2022 & 2033, By Country
Figure 55: Latin America Market Attractiveness Analysis, By Type
Figure 56: Latin America Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 57: Latin America Market Attractiveness Analysis, By Drug Class
Figure 58: Latin America Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 59: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 60: Latin America Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 61: Europe Market, Snapshot
Figure 62: Europe Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 63: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 64: Europe Market Value Share, by Country Type (2022A)
Figure 65: Europe Market Value Share, by Type (2022A)
Figure 66: Europe Market Value Share, by Drug Class (2022A)
Figure 67: Europe Market Value Share, by Distribution Channel (2022A)
Figure 68: Europe Market Attractiveness Analysis, By Country
Figure 69: Europe Market Value Share Analysis, By Region, 2022 & 2033, By Country
Figure 70: Europe Market Attractiveness Analysis, By Type
Figure 71: Europe Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 72: Europe Market Attractiveness Analysis, By Drug Class
Figure 73: Europe Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 74: Europe Market Attractiveness Analysis, By Distribution Channel
Figure 75: Europe Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 76: CIS & Russia Market, Snapshot
Figure 77: CIS & Russia Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 78: CIS & Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 79: CIS & Russia Market Value Share, by Type (2022A)
Figure 80: CIS & Russia Market Value Share, by Drug Class (2022A)
Figure 81: CIS & Russia Market Value Share, by Distribution Channel (2022A)
Figure 82: CIS & Russia Market Attractiveness Analysis, By Type
Figure 83: CIS & Russia Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 84: CIS & Russia Market Attractiveness Analysis, By Drug Class
Figure 85: CIS & Russia Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 86: CIS & Russia Market Attractiveness Analysis, By Distribution Channel
Figure 87: CIS & Russia Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 88: Asia-Pacific ex. Japan & China Market, Snapshot
Figure 89: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 90: Asia-Pacific ex. Japan & China Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 91: Asia-Pacific ex. Japan & China Market Value Share, by Country Type (2022A)
Figure 92: Asia-Pacific ex. Japan & China Market Value Share, by Type (2022A)
Figure 93: Asia-Pacific ex. Japan & China Market Value Share, by Drug Class (2022A)
Figure 94: Asia-Pacific ex. Japan & China Market Value Share, by Distribution Channel (2022A)
Figure 95: Asia-Pacific ex. Japan & China Market Attractiveness Analysis, By Country
Figure 96: Asia-Pacific ex. Japan & China Market Value Share Analysis, By Region, 2022 & 2033, By Country
Figure 97: Asia-Pacific ex. Japan & China Market Attractiveness Analysis, By Type
Figure 98: Asia-Pacific ex. Japan & China Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 99: Asia-Pacific ex. Japan & China Market Attractiveness Analysis, By Drug Class
Figure 100: Asia-Pacific ex. Japan & China Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 101: Asia-Pacific ex. Japan & China Market Attractiveness Analysis, By Distribution Channel
Figure 102: Asia-Pacific ex. Japan & China Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 103: Japan Market, Snapshot
Figure 104: Japan Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 105: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 106: Japan Market Value Share, by Type (2022A)
Figure 107: Japan Market Value Share, by Drug Class (2022A)
Figure 108: Japan Market Value Share, by Distribution Channel (2022A)
Figure 109: Japan Market Attractiveness Analysis, By Type
Figure 110: Japan Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 111: Japan Market Attractiveness Analysis, By Drug Class
Figure 112: Japan Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 113: Japan Market Attractiveness Analysis, By Distribution Channel
Figure 114: Japan Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 115: China Market, Snapshot
Figure 116: China Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 117: China Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 118: China Market Value Share, by Type (2022A)
Figure 119: China Market Value Share, by Drug Class (2022A)
Figure 120: China Market Value Share, by Distribution Channel (2022A)
Figure 121: China Market Attractiveness Analysis, By Type
Figure 122: China Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 123: China Market Attractiveness Analysis, By Drug Class
Figure 124: China Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 125: China Market Attractiveness Analysis, By Distribution Channel
Figure 126: China Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Figure 127: MEA Market, Snapshot
Figure 128: MEA Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 129: MEA Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 130: MEA Market Value Share, by Country Type (2022A)
Figure 131: MEA Market Value Share, by Type (2022A)
Figure 132: MEA Market Value Share, by Drug Class (2022A)
Figure 133: MEA Market Value Share, by Distribution Channel (2022A)
Figure 134: MEA Market Attractiveness Analysis, By Country
Figure 135: MEA Market Value Share Analysis, By Region, 2022 & 2033, By Country
Figure 136: MEA Market Attractiveness Analysis, By Type
Figure 137: MEA Market Value Share Analysis, By Region, 2022 & 2033, By Type
Figure 138: MEA Market Attractiveness Analysis, By Drug Class
Figure 139: MEA Market Value Share Analysis, By Region, 2022 & 2033, By Drug Class
Figure 140: MEA Market Attractiveness Analysis, By Distribution Channel
Figure 141: MEA Market Value Share Analysis, By Region, 2022 & 2033, By Distribution Channel
Dyslipidemia Therapeutics Market